Circulating Biomarkers of Immune Activation Distinguish Viral Suppression from Nonsuppression in HAART-Treated Patients with Advanced HIV-1 Subtype C Infection
Open Access
- 1 January 2014
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-7
Abstract
Few studies have examined immune activation profiles in patients with advanced HIV-1 subtype C infection or assessed their potential to predict responsiveness to HAART. BioPlex, ELISA, and nephelometric procedures were used to measure plasma levels of inflammatory biomarkers in HIV-1 subtype C-infected patients sampled before and after 6 months of successful HAART; in patients failing HAART; and in uninfected controls. Prior to HAART, CXCL9, CXCL10,β2M, sTNF-R1, TGF-β1, IFN-γ, IL-6, TNF, and sCD14 were significantly elevated in HIV-1-infected patients compared to controls. All of these markers, with the exception of sTNF-R1, were also elevated in patients failing HAART. The persistently elevated levels of CXCL9, CXCL10, andβ2M in patients failing therapy in the setting of a marked reduction in these markers in patients on successful HAART suggest that they may be useful not only to monitor immune activation during HAART, but also to distinguish between good and poor responders. In the case of sCD14 and TGF-β1, the levels of these biomarkers remained persistently elevated despite HAART-induced virological suppression, a finding that is consistent with ongoing monocyte-macrophage activation, underscoring a potential role for adjuvant anti-inflammatory therapy.
Keywords
Funding Information
- Delegation of the European Union to South Africa
- South African Medical Research Council
This publication has 40 references indexed in Scilit:
- The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of womenAIDS, 2011
- Cytoplasmic DNA innate immune pathwaysImmunological Reviews, 2011
- Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian CancerCancer Research, 2011
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV InfectionThe Journal of Infectious Diseases, 2011
- Plasma cytokine levels during acute HIV-1 infection predict HIV disease progressionAIDS, 2010
- Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV InfectionThe Journal of Infectious Diseases, 2009
- Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis CGastroenterology, 2008
- Chronic innate immune activation as a cause of HIV-1 immunopathogenesisClinical Immunology, 2008
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of TherapyThe Journal of Infectious Diseases, 2008
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006